checkAd

Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021

Nachrichtenquelle: globenewswire
17.02.2021, 09:36  |  152   |   |   

Bagsværd, Denmark, 17 February 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

Handeln Sie Ihre Einschätzung zu Novo-Nordisk AS!
Short
Basispreis 467,38€
Hebel 14,39
Ask 0,41
Long
Basispreis 409,86€
Hebel 13,74
Ask 0,42

Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

Please find below a statement of such trading in shares issued by Novo Nordisk.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name of the Board member/Executive/Associated Person Maha Kutay
2 Reason for the notification
a) Position/status Closely related to Kasim Kutay, member of the Board of Directors
b) Initial notification/Amendment Amendment to company announcement no. 12 / 2021 which erroneously stated Kasim Kutay in section 1a)
3 Details of the issuer
a) Name Novo Nordisk A/S
b) LEI 549300DAQ1CVT6CXN342
4 Details of the transaction(s)
a) Description of the financial instrument,
type of instrument,
Shares

 
  Identification code Novo Nordisk B DK0060534915
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)        
  Price(s) Volume(s)  
  DKK 463.11 552 shares  
       
       
d) Aggregated information
  • Aggregated volume
  • Price
 
Seite 1 von 3
Novo Nordisk (B) Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen
Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021 Bagsværd, Denmark, 17 February 2021 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel